SAB Biotherapeutics Announces Election of Rear Admiral (retired) Scott Giberson, RPh, MPH, D.Sc., to Board of Directors

SIOUX FALLS, S.D., July 11, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ:SABS ), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully human polyclonal antibodies without the need for human donors, today announced the appointment of Rear Admiral (RADM), retired, Scott Giberson, a former Assistant U.S. Surgeon General and two-star admiral with the U.S. Public Health Service to SAB's Board of Directors, effective July 7, 2022. RADM Giberson retired after a decorated career and 27 years of service. In 2018, the Military Officers Association of America selected him as one of the "Top 100 Veterans in the Last 100 Years you Need to Know." Currently, RADM (ret.) Giberson is the President of AMI Expeditionary Healthcare, a company that provides medical services to international aid organizations, humanitarian concerns, the private sector and government agencies in a wide range of remote and challenging environments. "RADM (ret.) Scott Giberson's impressive career working in the U.S. government combined with expertise in healthcare is a valuable and welcomed addition to SAB's Board of Directors," said Samuel J. Reich, Executive Chairman of SAB. "As SAB continues to develop and harness our proprietary technology to address today's most pressing unmet medical needs, we look forward to RADM (ret.) Giberson's future contributions to the Board." RADM (ret.) Giberson served as the acting Deputy Surgeon General of the United States (2013-2014), where he worked with the U.S. Surgeon General to develop and deliver scientific information to the public. In that role, he served as the Surgeon General's principal liaison with health leadership in the Department of Defense, Department of Homeland Security, and Department of Health and Human Services, among others. He held additional executive positions as the Senior Advisor to the Office of Surgeon General, Director of Commissioned Corps Headquarters, Chief Pharmacist of the U. S. Public Health Service, and Senior ... Full story available on